申请人:Sandoz Ltd.
公开号:US04137331A1
公开(公告)日:1979-01-30
This invention provides new compounds of formula I, ##STR1## wherein Het is a radical formed by removing one of the hydrogens from the phenyl ring of 2-indolinone or fluorenone, and R is the group A, B, C or D, ##STR2## wherein N IS THE NUMBER 2 OR 3, n' is the number 1, 2, 3 or 4, and X-x' is ethylene or vinylene, Wherein in group D each of the two C atoms adjacent to the N atom are identically substituted by hydrogen or by one or two alkyl groups of 1 to 4 carbon atoms useful as antiarrhythmic agents.
这项发明提供了新的化合物,其化学式为I,其中Het是通过从2-吲哚酮或氟伦酮的苯环中去除一个氢原子形成的基团,而R是A、B、C或D组,其中N为数字2或3,n'为数字1、2、3或4,X-x'为乙烯或乙烯基,其中在D组中,N原子相邻的两个C原子分别被氢或1至4个碳原子的一个或两个烷基基团取代,这些化合物可用作抗心律失常药物。